Stayble Therapeutics AB (publ) (STO:STABL)

Sweden flag Sweden · Delayed Price · Currency is SEK
0.3000
-0.0040 (-1.32%)
Sep 15, 2025, 4:24 PM CET
-1.32%
Market Cap19.31M
Revenue (ttm)n/a
Net Income (ttm)-9.27M
Shares Out64.36M
EPS (ttm)-0.19
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume223,574
Average Volume355,382
Open0.2350
Previous Close0.3040
Day's Range0.2350 - 0.3295
52-Week Range0.2730 - 1.0000
Beta-0.15
RSI38.02
Earnings DateNov 14, 2025

About Stayble Therapeutics AB

Stayble Therapeutics AB (publ) develops injectable treatment for chronic pain triggered by disc degeneration. The company develops STA363, an injection into the disc that targets chronic low back and leg pain. Stayble Therapeutics AB (publ) was incorporated in 2015 and is based in Gothenburg, Sweden. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2015
Employees 2
Stock Exchange Nasdaq Stockholm
Ticker Symbol STABL
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.